FDA Approved Medical Products for:

Chronic Infantile Neurological Cutaneous Articular syndrome

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Rilonacept
Trade Name
(Manufacturer Name)
Arcalyst®
(Regeneron Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of Cryopyrin-Assisted Periodic Syndromes (CAPS)
More Information about this product Drug Information Portal

Generic Name Anakinra
Trade Name
(Manufacturer Name)
Kineret
(Swedish Orphan Biovitrum AB (publ))
Indication
The FDA has approved this product to be used in this manner.
Treatment of neonatal-onset multisystem inflammatory disease (NOMID)
More Information about this product Drug Information Portal
Medline Plus Health Information